MEDICAL SERVICES

Departments

Programs

Languages

  • English

CERTIFICATIONS

  • American Board of Dermatology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Race and gender differences in systemic sclerosis: a retrospective multicenter cohort. Int J Dermatol. 2021 Sep 12. View abstract
  2. Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from two academic medical centers. J Am Acad Dermatol. 2021 Jul 08. View abstract
  3. Recognition and Management of Cutaneous Connective Tissue Diseases. Med Clin North Am. 2021 Jul; 105(4):757-782. View abstract
  4. Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus. JAMA Dermatol. 2021 Jul 01; 157(7):880-882. View abstract
  5. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2021 06 18; 60(6):2615-2628. View abstract
  6. Familial chilblain lupus in a child with heterozygous mutation in SAMHD1 and normal interferon signature. Br J Dermatol. 2021 09; 185(3):650-652. View abstract
  7. Dermatology education in internal medicine residency programs: A nationwide survey of program directors. J Am Acad Dermatol. 2021 Aug; 85(2):482-484. View abstract
  8. Treatment of Severe Multicentric Reticulohistiocytosis With Upadacitinib. JAMA Dermatol. 2021 Jun 01; 157(6):735-737. View abstract
  9. Lack of association between tumor necrosis factor-a inhibitor use and exacerbation of lupus erythematosus: A retrospective cohort study. J Am Acad Dermatol. 2021 Apr 30. View abstract
  10. Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sarcoidosis. J Am Acad Dermatol. 2021 Apr 30. View abstract
  11. Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients. JAAD Int. 2021 Jun; 3:111-114. View abstract
  12. The catch-22 of limited Food and Drug Administration approval for connective tissue disease therapies. J Am Acad Dermatol. 2021 Aug; 85(2):517-519. View abstract
  13. Clinical features and eosinophilia in pityriasis rubra pilaris: A multicenter cohort. J Am Acad Dermatol. 2021 Mar 24. View abstract
  14. Geographic distribution and environmental triggers of systemic sclerosis cases from 2 large academic tertiary centers in Massachusetts. J Am Acad Dermatol. 2021 Mar 23. View abstract
  15. Challenges of securing insurance approval for oral tofacitinib for the treatment of alopecia areata: a multi-institution retrospective review. Arch Dermatol Res. 2021 Jan 05. View abstract
  16. Porphyria Cutanea Tarda Masquerading as Systemic Sclerosis: Two Cases Demonstrating an Important Clinical Observation. J Rheumatol. 2021 01 01; 48(1):145-146. View abstract
  17. Early Features of Progressive Hemifacial Atrophy-Clinical and Imaging Findings. JAMA Dermatol. 2020 12 01; 156(12):1376-1379. View abstract
  18. Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus: A Retrospective Review of 61 Patients. JAMA Dermatol. 2020 11 01; 156(11):1264-1266. View abstract
  19. Practice gaps in the evaluation of systemic involvement in patients with cutaneous sarcoidosis presenting to a dermatologist: A retrospective review of 48 patients. J Am Acad Dermatol. 2021 Sep; 85(3):794-796. View abstract
  20. Strategies for effective medical student education in dermatology during the COVID-19 pandemic. J Am Acad Dermatol. 2021 01; 84(1):e33-e34. View abstract
  21. Dermatomyositis: An Update on Diagnosis and Treatment. Am J Clin Dermatol. 2020 Jun; 21(3):339-353. View abstract
  22. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea. JAMA Dermatol. 2020 05 01; 156(5):521-528. View abstract
  23. Mycophenolate Mofetil for Eosinophilic Fasciitis: A Retrospective Analysis From 3 Tertiary Care Centers. JAMA Dermatol. 2020 05 01; 156(5):595-597. View abstract
  24. A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents. JAMA Dermatol. 2020 04 01; 156(4):384-392. View abstract
  25. A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria. JAMA Dermatol. 2020 03 01; 156(3):270-279. View abstract
  26. Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer. JAMA Dermatol. 2020 01 01; 156(1):103-104. View abstract
  27. Intravenous Immunoglobulin for Refractory Eosinophilic Fasciitis: A Retrospective Analysis from 3 Tertiary Care Centers. J Am Acad Dermatol. 2019 Dec 14. View abstract
  28. Facing Uncertainty. N Engl J Med. 2019 Dec 05; 381(23):2253-2259. View abstract
  29. Facing Uncertainty. N Engl J Med. 2019 Nov 28; 381(22):e39. View abstract
  30. Willingness-to-pay stated preferences in cutaneous lupus erythematosus: a pilot study. Arch Dermatol Res. 2020 Sep; 312(7):527-531. View abstract
  31. Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis. N Engl J Med. 2019 Aug 01; 381(5):465. View abstract
  32. Augmented reality in dermatology: Are we ready for AR? J Am Acad Dermatol. 2019 Nov; 81(5):1216-1222. View abstract
  33. Systemic Treatment for Clinically Amyopathic Dermatomyositis at 4 Tertiary Care Centers. JAMA Dermatol. 2019 Apr 01; 155(4):494-496. View abstract
  34. Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine. JAMA Dermatol. 2019 Apr 01; 155(4):491-493. View abstract
  35. Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes. JAMA Dermatol. 2019 04 01; 155(4):455-459. View abstract
  36. Pityriasis rubra pilaris: A study evaluating patient quality of life in 2 populations. J Am Acad Dermatol. 2019 08; 81(2):638-640. View abstract
  37. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. J Invest Dermatol. 2019 02; 139(2):270-276. View abstract
  38. Academic dermatology leadership in the United States -- Addressing the gender gap. Int J Womens Dermatol. 2018 Dec; 4(4):236-237. View abstract
  39. Dermatology subspecialty clinic for patients with connective tissue disease impacts diagnosis and treatment: A single-center, retrospective analysis. J Am Acad Dermatol. 2021 08; 85(2):476-478. View abstract
  40. Lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutis. Br J Dermatol. 2018 06; 178(6):1412-1415. View abstract
  41. Subacute Cutaneous Lupus Erythematosus Induced by Palbociclib. J Cutan Med Surg. 2018 May/Jun; 22(3):341-343. View abstract
  42. Hidradenitis suppurativa burden of disease tool: Pilot testing of a disease-specific quality of life questionnaire. J Am Acad Dermatol. 2018 01; 78(1):215-217.e2. View abstract
  43. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol. 2018 04; 78(4):776-785. View abstract
  44. Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment. Curr Rheumatol Rep. 2017 Nov 04; 19(12):74. View abstract
  45. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis. JAMA Dermatol. 2017 11 01; 153(11):1147-1157. View abstract
  46. Sex and leadership in academic dermatology: A nationwide survey. J Am Acad Dermatol. 2017 10; 77(4):782-784. View abstract
  47. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus. JAMA Dermatol. 2017 09 01; 153(9):937-939. View abstract
  48. Antimelanoma Differentiation-associated Gene 5 Dermatomyositis. J Rheumatol. 2017 06; 44(6):850-851. View abstract
  49. Asymptomatic papules after breast cancer treatment. J Am Acad Dermatol. 2017 May; 76(5):e157-e158. View abstract
  50. Asymptomatic papules after breast cancer treatment. J Am Acad Dermatol. 2017 May; 76(5):e157-e158. View abstract
  51. Novel Application of High-Dose-Rate Brachytherapy for Severe, Recalcitrant Acrodermatitis Continua of Hallopeau. JAMA Dermatol. 2017 04 01; 153(4):331-332. View abstract
  52. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon ß in dermatomyositis. Br J Dermatol. 2017 May; 176(5):1224-1230. View abstract
  53. Expanding the use of the Cutaneous Dermatomyositis Area and Severity Index (CDASI) to nondermatologists. Br J Dermatol. 2017 02; 176(2):296-297. View abstract
  54. Segmental stiff skin syndrome (SSS): Two additional cases with a positive response to mycophenolate mofetil and physical therapy. J Am Acad Dermatol. 2016 Dec; 75(6):e237-e239. View abstract
  55. Characteristics and treatment of postirradiation morphea: A retrospective multicenter analysis. J Am Acad Dermatol. 2017 Jan; 76(1):19-21. View abstract
  56. Unilateral Gottron Papules in a Patient Following a Stroke: Clinical Insights Into the Disease Mechanisms and Pathophysiology of Cutaneous Dermatomyositis. JAMA Dermatol. 2016 09 01; 152(9):1062-3. View abstract
  57. Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment. JAMA Dermatol. 2016 08 01; 152(8):944-5. View abstract
  58. Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions. J Am Acad Dermatol. 2016 Jul; 75(1):210-2. View abstract
  59. Sharps injuries among US dermatology trainees: A cross-sectional study. J Am Acad Dermatol. 2016 Apr; 74(4):756-8. View abstract
  60. Characteristics and treatment of adult-onset linear morphea: A retrospective cohort study of 61 patients at 3 tertiary care centers. J Am Acad Dermatol. 2016 Mar; 74(3):577-9. View abstract
  61. Dapsone for treatment of erythema nodosum. Dermatol Online J. 2016 Feb 17; 22(2). View abstract
  62. Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis. Clin Exp Dermatol. 2016 Jul; 41(5):498-501. View abstract
  63. Development and Pilot Testing of the Cutaneous Lupus Screening Tool. JAMA Dermatol. 2016 Jan; 152(1):60-6. View abstract
  64. Epidemiology and Treatment of Eosinophilic Fasciitis: An Analysis of 63 Patients From 3 Tertiary Care Centers. JAMA Dermatol. 2016 Jan; 152(1):97-9. View abstract
  65. Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy. JAMA Dermatol. 2015 Dec 01; 151(12):1354-1357. View abstract
  66. Cutaneous dermatomyositis in the era of biologicals. Semin Immunopathol. 2016 Jan; 38(1):113-21. View abstract
  67. Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): experience of a tertiary medical center. J Am Acad Dermatol. 2015 Oct; 73(4):701-2. View abstract
  68. The Value of the Black Box Warning in Dermatology. J Drugs Dermatol. 2015 Jul; 14(7):660-6. View abstract
  69. Severe Tacrolimus-Induced Granulomatous Rosacea Recalcitrant to Oral Tetracyclines. J Drugs Dermatol. 2015 Jun; 14(6):628-30. View abstract
  70. Teledermatology perception differences between urban primary care physicians and dermatologists. JAMA Dermatol. 2015 Mar; 151(3):339-40. View abstract
  71. Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade. JAMA Dermatol. 2015 Feb; 151(2):195-9. View abstract
  72. Tense bullae on the palms and soles. JAMA Dermatol. 2015 Jan; 151(1):99-100. View abstract
  73. Facial erythromelalgia: a rare entity to consider in the differential diagnosis of connective tissue diseases. J Am Acad Dermatol. 2014 Dec; 71(6):e250-1. View abstract
  74. Clinicopathologic lessons in distinguishing cicatricial alopecia: 7 cases of lichen planopilaris misdiagnosed as discoid lupus. J Am Acad Dermatol. 2014 Oct; 71(4):e135-8. View abstract
  75. Paraproteinemia-associated scleredema treated successfully with intravenous immunoglobulin. JAMA Dermatol. 2014 Jul; 150(7):788-9. View abstract
  76. A 52-year-old woman with subcutaneous nodules and abdominal pain. Clin Exp Dermatol. 2014 Jun; 39(4):547-9. View abstract
  77. Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer. 2014 Apr 02; 110(7):1855-61. View abstract
  78. Creation of a novel, interdisciplinary, multisite clerkship: "understanding lupus". Acad Med. 2014 Mar; 89(3):404-9. View abstract
  79. Cutaneous lupus erythematosus. JAMA Dermatol. 2014 Mar; 150(3):344. View abstract
  80. Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center. JAMA Dermatol. 2014 Jan; 150(1):92-4. View abstract
  81. Case records of the Massachusetts General Hospital. Case 39-2013. A 57-year-old woman with painful bullous skin lesions. N Engl J Med. 2013 Dec 19; 369(25):2438-49. View abstract
  82. Multiple tense bullae localized to the right breast in a woman in her seventies. JAMA Dermatol. 2013 Dec; 149(12):1427-8. View abstract
  83. Lupus erythematosus panniculitis-induced facial atrophy: effective treatment with poly-L-lactic acid and hyaluronic acid dermal fillers. J Am Acad Dermatol. 2013 Nov; 69(5):e260-e262. View abstract
  84. Lower-dose thalidomide therapy effectively treats cutaneous lupus erythematosus but is limited by neuropathic toxicity. Int J Dermatol. 2013 Nov; 52(11):1407-9. View abstract
  85. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center. J Am Acad Dermatol. 2013 Oct; 69(4):654-7. View abstract
  86. Psoriasiform reactions to anti-tumor necrosis factor a therapy. J Clin Rheumatol. 2013 Oct; 19(7):377-81. View abstract
  87. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis. JAMA Dermatol. 2013 Oct; 149(10):1204-8. View abstract
  88. Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol. 2013 Aug; 14(4):291-313. View abstract
  89. Methotrexate for the treatment of cutaneous dermatomyositis. J Am Acad Dermatol. 2013 Jun; 68(6):1043-5. View abstract
  90. Images in clinical medicine. Epidermolysis bullosa acquisita. N Engl J Med. 2013 Mar 28; 368(13):e17. View abstract
  91. Diffuse dystrophic calcinosis cutis of the scalp in a patient with scalp discoid lupus erythematosus and systemic lupus erythematosus. JAMA Dermatol. 2013 Feb; 149(2):246-8. View abstract
  92. Full facial edema: a novel presentation of subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol. 2012 Sep 01; 30(25):e233-6. View abstract
  93. Panniculitis associated with dermatomyositis and recurrent ovarian cancer. Arch Dermatol. 2012 Jun; 148(6):740-4. View abstract
  94. Calcinosis cutis: an additional therapy to consider. J Am Acad Dermatol. 2012 Jun; 66(6):1004-5; author reply 1005. View abstract
  95. Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol. 2012 May; 39(5):526-34. View abstract
  96. Management of cutaneous dermatomyositis. Dermatol Ther. 2012 Mar-Apr; 25(2):112-34. View abstract
  97. A population-based study of acne and body mass index in adolescents. Arch Dermatol. 2012 Jan; 148(1):131-2. View abstract
  98. Calciphylaxis: a systematic review of existing and emerging therapies. J Am Acad Dermatol. 2012 Dec; 67(6):e253-60. View abstract
  99. Identifying when therapy for one skin disease is likely to exacerbate another skin condition. Arch Dermatol. 2011 Jul; 147(7):836. View abstract
  100. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-a therapy: a novel cause of noncicatricial alopecia. Am J Dermatopathol. 2011 Apr; 33(2):161-6. View abstract
  101. RNA interference of insulin-related peptide and neuroparsins affects vitellogenesis in the desert locust Schistocerca gregaria. Peptides. 2011 Mar; 32(3):573-80. View abstract
  102. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-a inhibitor therapy. A study of 16 biopsies. Am J Dermatopathol. 2010 Aug; 32(6):568-73. View abstract
  103. Interactive medical case. A rash hypothesis. N Engl J Med. 2010 Jun 17; 362(24):e69. View abstract
  104. The role of octopamine in locusts and other arthropods. J Insect Physiol. 2010 Aug; 56(8):854-67. View abstract
  105. The cloning, phylogenetic relationship and distribution pattern of two new putative GPCR-type octopamine receptors in the desert locust (Schistocerca gregaria). J Insect Physiol. 2010 Aug; 56(8):868-75. View abstract
  106. Mitochondrial DNA deletions serve as biomarkers of aging in the skin, but are typically absent in nonmelanoma skin cancers. J Invest Dermatol. 2006 Feb; 126(2):336-44. View abstract
  107. High-throughput mitochondrial genome screening method for nonmelanoma skin cancer using multiplexed temperature gradient capillary electrophoresis. Clin Chem. 2005 Feb; 51(2):305-11. View abstract